-Immunomic Therapeutics to receive upfront payment of $300 million plus 10 percent royalties from potential products for allergic diseases, including peanut allergy- -Immunomic Therapeutics to retain rights of LAMP-vax platform ...
HERSHEY, Pa. and ROCKVILLE, Md., Aug. 28, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP technology, today announces that ...
HERSHEY, Pa. and ROCKVILLE, Md., June 16, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP technology, today announces that ...
Immunomic Therapeutics, Inc. CEO, William Hearl, Ph.D. to Speak at 2015 BIO International Convention
HERSHEY, Pa. and ROCKVILLE, Md., June 3, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP technology, today announces that ...
HERSHEY, Pa. and ROCKVILLE, Md., May 13, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP technology, today announces that ...
HERSHEY, Pa. and ROCKVILLE, Md., May 6, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company developing vaccines based on its proprietary LAMP technology, today announces it ...
HERSHEY, Pa. and ROCKVILLE, Md., May 4, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. (ITI), a privately-held biotechnology company developing vaccines based on its proprietary LAMP technology, today announces it ...
HERSHEY, Pa. and ROCKVILLE, Md., March 31, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP technology, today announces that ...
Hershey, PA, & Rockville, MD – March 9, 2015 – Immunomic Therapeutics, Inc., (“ITI”) a privately-held biotechnology company developing vaccines based on its proprietary LAMP technology, today announces it will ...
HERSHEY, PA & ROCKVILLE, MD (PRWEB) FEBRUARY 10, 2015 Immunomic Therapeutics, Inc. (ITI) announced today that Timothy Coleman Ph.D. has joined the company to further develop a comprehensive growth plan and ...
HERSHEY, Pa., Rockville, Md. and TOKYO, Jan. 29, 2015 /PRNewswire/ -- Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into ...
HERSHEY, PA AND SAN FRANCISCO, CA (PRWEB) JANUARY 09, 2015 Immunomic Therapeutics, Inc., (ITI), a pioneering vaccine company, announced today that Dr. William Hearl, the Company’s President and CEO, will be ...